GasGene
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A Chinese biotech developing gas-based therapeutics and delivery systems for cardiovascular and respiratory diseases.
CardiovascularRespiratory
Technology Platform
A proprietary platform for the stabilization, formulation, and targeted delivery of therapeutic medical gases (e.g., hydrogen, nitric oxide) for disease treatment.
Opportunities
First-mover advantage in the novel field of gas-based therapeutics for large, underserved chronic disease markets.
Risk Factors
High scientific and clinical development risk associated with pioneering a new therapeutic modality and its unique delivery challenges.
Competitive Landscape
Operates in a highly specialized and emerging field with few direct competitors, but must prove the entire therapeutic class.